{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:07:00Z","timestamp":1792620420427,"version":"4.5.0"},"reference-count":82,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,7,31]],"date-time":"2015-07-31T00:00:00Z","timestamp":1438300800000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.6061\/clinics\/2015(07)09","type":"journal-article","created":{"date-parts":[[2015,7,14]],"date-time":"2015-07-14T14:58:31Z","timestamp":1436885911000},"page":"515-523","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":271,"title":["Cytomegalovirus infection in transplant recipients"],"prefix":"10.1016","volume":"70","author":[{"given":"Luiz Sergio","family":"Azevedo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00edgia Camera","family":"Pierrotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edson","family":"Abdala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia Figueiredo","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T\u00e2nia Mara Varej\u00e3o","family":"Strabelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia Vidal","family":"Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9ssica Fernandes","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Acram Zahredine Abdul","family":"Latif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Litvinov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalya Zaidan","family":"Maluf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helio Hehl Caiaffa","family":"Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio Sergio","family":"Pannuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta Heloisa","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera Aparecida","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila","family":"da Cruz Gouveia Linardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Aparecida Shikanai","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heloisa Helena","family":"de Sousa Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.6061\/clinics\/2015(07)09_bib1","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1172\/JCI45449","article-title":"Cytomegalovirus: pathogen, paradigm, and puzzle","volume":"121","author":"Boeckh","year":"2011","journal-title":"J Clin Invest"},{"issue":"4","key":"10.6061\/clinics\/2015(07)09_bib2","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1590\/S0037-86822010000400004","article-title":"Sero-prevalence of cytomegalovirus antibodies in blood donors in southern, Brazil","volume":"43","author":"Souza","year":"2010","journal-title":"Rev Soc Bras Med Trop"},{"issue":"9","key":"10.6061\/clinics\/2015(07)09_bib3","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1086\/508173","article-title":"Seroprevalence of cytomegalovirus infection in the United States, 1988\u20131994","volume":"43","author":"Staras","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.6061\/clinics\/2015(07)09_bib4","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1590\/S0037-86821995000200003","article-title":"Prevalence of cytomegalovirus infection in different patient groups of an urban university in Brazil","volume":"28","author":"Suassuna","year":"1995","journal-title":"Rev Soc Bras Med Trop"},{"issue":"12","key":"10.6061\/clinics\/2015(07)09_bib5","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S1473-3099(04)01202-2","article-title":"Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments","volume":"4","author":"Gandhi","year":"2004","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"10.6061\/clinics\/2015(07)09_bib6","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1086\/339329","article-title":"Definitions of cytomegalovirus infection and disease in transplant recipients","volume":"34","author":"Ljungman","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.6061\/clinics\/2015(07)09_bib7","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0891-5520(05)70158-6","article-title":"Infectious complications of solid organ transplantations","volume":"15","author":"Simon","year":"2001","journal-title":"Infect Dis Clin of North Am"},{"issue":"2","key":"10.6061\/clinics\/2015(07)09_bib8","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1399-0012.2006.00618.x","article-title":"Cytomegalovirus in transplantation - challenging the status quo","volume":"21","author":"Fishman","year":"2007","journal-title":"Clin Transplant"},{"issue":"Suppl 4","key":"10.6061\/clinics\/2015(07)09_bib9","first-page":"S76","article-title":"Cytomegalovirus in solid organ transplant recipients","volume":"9","author":"Humar","year":"2009","journal-title":"Am J Transplant"},{"issue":"2","key":"10.6061\/clinics\/2015(07)09_bib10","first-page":"23","article-title":"Monitoring of human cytomegalovirus, HHV-6 and HHV-7 infection in kidney transplant recipients by molecular methods to predict HCMV disease after transplantation: a prospective study","volume":"10","author":"Rayes","year":"2005","journal-title":"Ann Transplant"},{"issue":"1","key":"10.6061\/clinics\/2015(07)09_bib11","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1136\/jmg.2009.068841","article-title":"Association between a polymorphism in the human programmed death-1 (PD-1) gene and cytomegalovirus infection after kidney transplantation","volume":"47","author":"Hoffmann","year":"2009","journal-title":"J Med Genet"},{"issue":"9","key":"10.6061\/clinics\/2015(07)09_bib12","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S1083-8791(03)00287-8","article-title":"Cytomegalovirus in hematopoietic stem cell transplant recipients: current status, known challenges, and future strategies","volume":"9","author":"Boeckh","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"issue":"12","key":"10.6061\/clinics\/2015(07)09_bib13","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1097\/TP.0b013e3181ff1493","article-title":"Extended valganciclovir prophylaxis in D+\/R- transplant recipients is associated with long-term reduction in cytomegalovirus disease: two-year results of IMPCT study","volume":"90","author":"Humar","year":"2010","journal-title":"Transplantation"},{"issue":"5","key":"10.6061\/clinics\/2015(07)09_bib14","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1086\/527397","article-title":"Improving outcomes for solid-organ transplant recipients at risk from cytomegalovirus infection: late-onset disease and indirect consequences","volume":"46","author":"Legendre","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.6061\/clinics\/2015(07)09_bib15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1399-3062.2011.00705.x","article-title":"Risk factors and clinical outcomes of cytomegalovirus disease occurring more than one year post solid organ transplantation","volume":"14","author":"Blyth","year":"2012","journal-title":"Transpl Infect Dis"},{"issue":"Suppl 1","key":"10.6061\/clinics\/2015(07)09_bib16","first-page":"8","article-title":"Indirect effects of CMV in the solid organ transplant patient","volume":"1","author":"Paya","year":"1999","journal-title":"Transpl. Infect Dis"},{"issue":"11","key":"10.6061\/clinics\/2015(07)09_bib17","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1111\/j.1600-6143.2009.02824.x","article-title":"The indirect effects of cytomegalovirus infection","volume":"9","author":"Freeman","year":"2009","journal-title":"Am J Transpl"},{"issue":"1","key":"10.6061\/clinics\/2015(07)09_bib18","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/ctr.12288","article-title":"The inpact of early cytomegalovirus infection after kidney transplantation on long-term graft and patient survival","volume":"28","author":"Smedbraten","year":"2014","journal-title":"Clin Transplant"},{"issue":"Suppl 10","key":"10.6061\/clinics\/2015(07)09_bib19","first-page":"51","article-title":"American Society of Transplantation (AST).Cytomegalovirus guidelines for the prevention and management of infectious complications of solid organ transplantation","volume":"4","year":"2004","journal-title":"Am J Transplant"},{"issue":"2","key":"10.6061\/clinics\/2015(07)09_bib20","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1600-6143.2004.00692.x","article-title":"Canadian Society of Transplantation consensus workshop on cytomegalovirus management in solid organ transplantation final report","volume":"5","author":"Preiksaitis","year":"2005","journal-title":"Am J Transplant"},{"issue":"8","key":"10.6061\/clinics\/2015(07)09_bib21","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1086\/339329","article-title":"Difinitions of cytomegalovirus infection and disease in transplant recipients","volume":"34","author":"Ljungman","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.6061\/clinics\/2015(07)09_bib22","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1600-6143.2005.01207.x","article-title":"American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunossuppression trials in recipients of organ transplantation","volume":"6","author":"Humar","year":"2006","journal-title":"Am J Transpl"},{"issue":"12","key":"10.6061\/clinics\/2015(07)09_bib23","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1097\/00007890-199712270-00016","article-title":"Comparative study of cytomegalovirus (CMV) antigenemia assay, polymerase chain reaction, and shell vial assay in the early diagnosis and monitoring of CMV infection after real transplantation","volume":"64","author":"Tanabe","year":"1997","journal-title":"Transplantation"},{"issue":"2","key":"10.6061\/clinics\/2015(07)09_bib24","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1086\/315242","article-title":"Cytomegalovirus (CMV) DNA load predicts relapsing CMV infection after solid organ transplantation","volume":"181","author":"Sia","year":"2000","journal-title":"J Infect Dis"},{"issue":"8","key":"10.6061\/clinics\/2015(07)09_bib25","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1097\/00007890-199504000-00010","article-title":"Comparison of polymerase chain reaction from plasma and buffy coat with antigen detection and occurrence of immunoglobulin M for the demonstration of cytomegalovirus infection after liver transplantation","volume":"59","author":"Schmidt","year":"1995","journal-title":"Transplantation"},{"issue":"6","key":"10.6061\/clinics\/2015(07)09_bib26","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1399-3046.2004.00242.x","article-title":"Strategies for the prevention of cytomegalovirus infection and disease in pediatric liver transplantation recipients","volume":"8","author":"Campbell","year":"2004","journal-title":"Pediatr Transplant"},{"issue":"Supl 9","key":"10.6061\/clinics\/2015(07)09_bib27","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0213-005X(08)76542-X","article-title":"Infecciones en el paciente inmunodeprimido","volume":"26","author":"Marcosa","year":"2008","journal-title":"Enferm Infecc Microbiol Clin"},{"issue":"4","key":"10.6061\/clinics\/2015(07)09_bib28","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/TP.0b013e31829df29d","article-title":"Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation","volume":"96","author":"Kotton","year":"2013","journal-title":"Transplantation"},{"issue":"3","key":"10.6061\/clinics\/2015(07)09_bib29","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1128\/CMR.11.3.533","article-title":"Quantitation o cytomegalovirus: methodologic aspects and clinical applications","volume":"11","author":"Boeckh","year":"1998","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"10.6061\/clinics\/2015(07)09_bib30","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1128\/JCM.40.3.746-752.2002","article-title":"Role of the laboratory in diagnosis and management of cytomegalovirus infection in hematopoietic stem cell and solid-organ transplant recipients","volume":"40","author":"Razonable","year":"2002","journal-title":"J Clin Microbiol"},{"issue":"10","key":"10.6061\/clinics\/2015(07)09_bib31","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.eimc.2011.05.022","article-title":"GESITRA-SEIMC recommendations for the management of cytomegalovirus infection in solid-organ transplant patients","volume":"29","author":"Torre-Cisneros","year":"2011","journal-title":"Enferm Infecc Microbiol Clin"},{"issue":"1","key":"10.6061\/clinics\/2015(07)09_bib32","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/tid.12015","article-title":"Clinical significance of quantitative cytomegalovirus detection in bronchoalveolar lavage fluid in lung transplant recipients","volume":"15","author":"Schlischewsky","year":"2013","journal-title":"Transpl Infect Dis"},{"issue":"4","key":"10.6061\/clinics\/2015(07)09_bib33","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jcv.2011.04.007","article-title":"Cytomegalovirus quantification: where to next in optimizing patient management","volume":"51","author":"Atkinson","year":"2011","journal-title":"J Clin Virol"},{"issue":"2","key":"10.6061\/clinics\/2015(07)09_bib34","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1399-0012.2007.00778.x","article-title":"Cytomegalovirus viremia in solid organ transplantation: does the initial viral load correlate with risk factors and outcomes","volume":"22","author":"Levitsky","year":"2008","journal-title":"Clin Transplant"},{"issue":"9","key":"10.6061\/clinics\/2015(07)09_bib35","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1111\/j.1600-6143.2006.01413.x","article-title":"Prophylactic versus preemptive oral valganciclovir for the management of cytomegalovirus infection in adult renal transplant recipients","volume":"6","author":"Khoury","year":"2006","journal-title":"Am J Transplant"},{"issue":"1","key":"10.6061\/clinics\/2015(07)09_bib36","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1600-6143.2007.02031.x","article-title":"Valacyclovir prophylaxis versus pre-emptive valganciclovir therapy to prevent cytomegalovirus disease after renal transplantation","volume":"8","author":"Reischig","year":"2008","journal-title":"Am J Transplant"},{"issue":"4","key":"10.6061\/clinics\/2015(07)09_bib37","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/sj.bmt.1704369","article-title":"Clinical significance of cytomegalovirus (CMV) antigenemia in the prediction and diagnosis of CMV gastrintestinal disease after allogeneic hematopoietic stem cell transplantation","volume":"33","author":"Mori","year":"2004","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"10.6061\/clinics\/2015(07)09_bib38","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1373\/49.10.1683","article-title":"Quantitative real-time PCR compared with pp65 antigen detection for cytomegalovirus (CMV) in 1122 blood specimens from 77 patients after allogeneic stem cell transplantation: which test better predicts CMV disease development","volume":"49","author":"Nitsche","year":"2003","journal-title":"Clin Chem"},{"issue":"3","key":"10.6061\/clinics\/2015(07)09_bib39","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1128\/JCM.42.3.1142-1148.2004","article-title":"Optimization of quantitative detection of cytomegalovirus DNA in plasma by real-time PCR","volume":"42","author":"Boeckh","year":"2004","journal-title":"J Clin Microbiol"},{"issue":"4","key":"10.6061\/clinics\/2015(07)09_bib40","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1128\/JCM.42.4.1498-1504.2004","article-title":"Validation of clinical application of cytomegalovirus plasma DNA load measurement and definition of treatment criteria by analysis of correlation to antigen detection","volume":"42","author":"Kalpoe","year":"2004","journal-title":"J Clin Microbiol"},{"issue":"4","key":"10.6061\/clinics\/2015(07)09_bib41","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/sj.bmt.1705558","article-title":"The effect of quantification standards used in real-time CMV PCR assays on guidelines for initiation of therapy in allogeneic stem cell transplant patients","volume":"39","author":"Harrington","year":"2007","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"10.6061\/clinics\/2015(07)09_bib42","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1128\/JCM.00797-08","article-title":"Quantification of DNA in plasma by an automated real-time PCR assay (cytomegalovirus PCR kit) for surveillance of active cytomegalovirus infection and guidance of preemptive therapy for allogeneic hematopoietic stem cell transplant recipients","volume":"46","author":"Gimeno","year":"2008","journal-title":"J Clin Microbiol"},{"issue":"suppl4","key":"10.6061\/clinics\/2015(07)09_bib43","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/ajt.12103","article-title":"Cytomegalovirus in solid organ transplantation","volume":"13","author":"Razonable","year":"2013","journal-title":"Am J Transplant"},{"issue":"11","key":"10.6061\/clinics\/2015(07)09_bib44","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/sj.bmt.1703055","article-title":"Foscarnet therapy for ganciclovir-resistant cytomegalovirus retinitis after stem cell transplantation: effective monitoring of CMV infection by quantitative analysis of CMV mRNA","volume":"27","author":"Ohta","year":"2001","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.6061\/clinics\/2015(07)09_bib45","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1182\/blood-2002-07-1982","article-title":"Emergence of late cytomegalovirus central nervous system disease in hematopoietic stem cell transplant recipients","volume":"101","author":"Wolf","year":"2003","journal-title":"Blood"},{"issue":"1","key":"10.6061\/clinics\/2015(07)09_bib46","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1128\/JCM.43.1.208-213.2005","article-title":"How evolution of mutations conferring drug resistance affects viral dynamics and clinical outcomes of cytomegalovirus-infected hematopoietic cell transplant recipients","volume":"43","author":"Springer","year":"2005","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.6061\/clinics\/2015(07)09_bib47","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/jmv.20150","article-title":"Cytomegalovirus antiviral resistance associated with treatment induced UL97 (protein kinase) and UL54 (DNA polymerase) mutations","volume":"74","author":"Scott","year":"2004","journal-title":"J Med Virol"},{"issue":"6","key":"10.6061\/clinics\/2015(07)09_bib48","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.mcp.2005.06.008","article-title":"Rapid detection of codon 460 mutations in the UL97 gene of ganciclovir-resistant cytomegalovirus clinical isolates by real-time PCR using molecular beacons","volume":"19","author":"Yeo","year":"2005","journal-title":"Mol Cell Probes"},{"issue":"13-14","key":"10.6061\/clinics\/2015(07)09_bib49","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/j.intimp.2006.07.022","article-title":"The emergence of cytomegalovirus resistance to ganciclovir therapy in kidney transplant recipients","volume":"6","author":"Nogueira","year":"2006","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"10.6061\/clinics\/2015(07)09_bib50","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jviromet.2007.12.011","article-title":"Development of SYBR Green I-based real-time PCR assay for detection of drug resistance mutations in cytomegalovirus","volume":"149","author":"Liu","year":"2008","journal-title":"J Virol Methods"},{"issue":"4","key":"10.6061\/clinics\/2015(07)09_bib51","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/QCO.0b013e32821f6026","article-title":"Prophylaxis and treatment of cytomegalovirus disease in recipients of solid organ transplants: current approach and future challenges","volume":"20","author":"Puius","year":"2007","journal-title":"Current Opinion Infect Dis"},{"issue":"3","key":"10.6061\/clinics\/2015(07)09_bib52","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/tid.12226","article-title":"Prevention strategies for cytomegalovirus disease and long-term outcomes in the high-risk transplant patients (D+\/R-): experience from the RESISTRA-REIPI cohort","volume":"16","author":"Meije","year":"2014","journal-title":"Transplant Infect Dis"},{"issue":"12","key":"10.6061\/clinics\/2015(07)09_bib53","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1093\/cid\/cis818","article-title":"State of art monitoring of cytomegalovirus-specific cell-mediated immunity after organ transplantation. A primer for the clinician","volume":"55","author":"Egli","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.6061\/clinics\/2015(07)09_bib54","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/TP.0b013e31823c1cd4","article-title":"Clinical utility of cytomegalovirus and cell-mediated immunity in transplant reciepients with cytomegalovirus viremia","volume":"93","author":"Lisboa","year":"2012","journal-title":"Transplantation"},{"issue":"6","key":"10.6061\/clinics\/2015(07)09_bib55","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/cid\/cis993","article-title":"Assessment of cytomegalovirus-specific cell-mediated immunity for the prediction of cytomegalovirus disease in high-risk solid-organ transplant recipients: a multicenter cohort study","volume":"56","author":"Manuel","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.6061\/clinics\/2015(07)09_bib56","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/ajt.12049","article-title":"Pretransplant interferon-gama secretion by CMV-specific CD8+ T cells informs the risk of CMV replication after transplantation","volume":"13","author":"Cantisan","year":"2013","journal-title":"Am J Transplant"},{"issue":"10","key":"10.6061\/clinics\/2015(07)09_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074744","article-title":"Clinical assessment of anti-viral CD8+ T cell immune monitoring using QuantiFERON-CMV\u00ae assay to identify high risk allogeneic hematopoietic stem cell transplant patients with CMV infection complications","volume":"8","author":"Tey","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.6061\/clinics\/2015(07)09_bib58","first-page":"e12","article-title":"Clinical immune-monitoring strategies for predicting infection risk in solid organ transplantation","volume":"3","author":"Fernadez-Ruiz","year":"2014","journal-title":"ClinTransl Immunology"},{"key":"10.6061\/clinics\/2015(07)09_bib59","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ijid.2014.06.009","article-title":"Trip to immunity: resistant cytomegalovirus infection in a lung transplant recipient","volume":"28","author":"Kneidinger","year":"2014","journal-title":"Int J infect Dis"},{"issue":"12","key":"10.6061\/clinics\/2015(07)09_bib60","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1097\/TP.0b013e3182708e56","article-title":"Is cytomegalovirus prophylaxis dispensable in patients receiving an mTOR inhibitor-based immunosuppression? A systematic review and meta-analysis","volume":"94","author":"Andrassy","year":"2012","journal-title":"Transplantation"},{"issue":"5","key":"10.6061\/clinics\/2015(07)09_bib61","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/j.1600-6143.2010.03074.x","article-title":"The efficacy and safety of 200 days valganciclovir cytomegalovirus prophylaxis in high risk kidney transplant recipients","volume":"10","author":"Humar","year":"2010","journal-title":"Am J Transplant"},{"issue":"1","key":"10.6061\/clinics\/2015(07)09_bib62","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1086\/375743","article-title":"Viral DNA polymerase mutations associated with drug resistance in human cytomegalovirus","volume":"188","author":"Chou","year":"2003","journal-title":"J Infect Dis"},{"issue":"12","key":"10.6061\/clinics\/2015(07)09_bib63","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1086\/504270","article-title":"Cytomegalovirus retinitis and viral resistance study group. Detection of ganciclovir resistance in patients with AIDS and cytomegalovirus retinitis: correlation of genotypic methods with viral phenotype and clinical outcome","volume":"193","author":"Jabs","year":"2006","journal-title":"J Infect Dis"},{"issue":"5","key":"10.6061\/clinics\/2015(07)09_bib64","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1086\/427506","article-title":"Late-onset cytomegalovirus disease as a significant complication in solid organ transplant recipients receiving antiviral prophylaxis: a call to heed the mounting evidence","volume":"40","author":"Singh","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.6061\/clinics\/2015(07)09_bib65","doi-asserted-by":"crossref","first-page":"870","DOI":"10.7326\/0003-4819-143-12-200512200-00005","article-title":"Meta-Analysis: the efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients","volume":"143","author":"Kalil","year":"2005","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.6061\/clinics\/2015(07)09_bib66","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1111\/j.1600-6143.2007.02133.x","article-title":"Improvement in long-term renal graft survival due to CMV prophylaxis with oral ganciclovir: Results of a randomized clinical trial","volume":"8","author":"Kliem","year":"2008","journal-title":"Am J Transplant"},{"issue":"10","key":"10.6061\/clinics\/2015(07)09_bib67","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1097\/TP.0000000000000189","article-title":"A double-blinded, prospective study to define antigenemia and quantitative real-time polymerase chain reaction cutoffs to start preemptive therapy in low risk, seropositive, renal transplanted patients","volume":"98","author":"David-Neto","year":"2014","journal-title":"Transplantation"},{"issue":"1","key":"10.6061\/clinics\/2015(07)09_bib68","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/TP.0b013e318238dab3","article-title":"Valganciclovir prophylaxis versus preemptive therapy in cytomegalovirus\u2013positive renal allograft recipients: 1-year results of a randomized clinical Trial","volume":"93","author":"Witzke","year":"2012","journal-title":"Transplantation"},{"issue":"4","key":"10.6061\/clinics\/2015(07)09_bib69","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/TP.0b013e3181e81afc","article-title":"Impact of prophylactic versus preemptive valganciclovir on long-term renal allograft outcomes","volume":"90","author":"Spinner","year":"2010","journal-title":"Transplantation"},{"issue":"suppl s7","key":"10.6061\/clinics\/2015(07)09_bib70","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/1469-0691.12594","article-title":"on behalf of the ESCMID Study Group of infection in compromised host (ESGICH). Cytomegalovirus infection in solid organ transplant recipients","volume":"20","author":"Lumbreras","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"9","key":"10.6061\/clinics\/2015(07)09_bib71","first-page":"913","article-title":"Randomized trial of daily versus three\u2013times-weekly prophylactic ganciclovir after lung and heart-lung transplantation","volume":"17","author":"Hertz","year":"1998","journal-title":"J Heart Lung Transplant"},{"issue":"9","key":"10.6061\/clinics\/2015(07)09_bib72","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1681\/ASN.2012010100","article-title":"Long-term outcomes of pre-emptive valganciclovir compared with valacyclovir prophylaxis for prevention of cytomegalovirus in renal transplantation","volume":"23","author":"Reischig","year":"2012","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.6061\/clinics\/2015(07)09_bib73","doi-asserted-by":"crossref","first-page":"294","DOI":"10.2215\/CJN.07020714","article-title":"Randomized Trial of valganciclovir versus valacyclovir prophylaxis for prevention of cytomegalovirus in renal transplantation","volume":"10","author":"Reischig","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"issue":"13","key":"10.6061\/clinics\/2015(07)09_bib74","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1056\/NEJMoa1303688","article-title":"CMX001 to prevent cytomegalovirus disease in hematopoietic cell transplantation","volume":"369","author":"Marty","year":"2013","journal-title":"N Eng J Med"},{"issue":"9","key":"10.6061\/clinics\/2015(07)09_bib75","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1111\/j.1600-6143.2007.01910.x","article-title":"Oral valganciclovir is non inferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients","volume":"7","author":"Asberg","year":"2007","journal-title":"Am J Transplant"},{"issue":"16","key":"10.6061\/clinics\/2015(07)09_bib76","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1056\/NEJM199904223401608","article-title":"Antiviral Drugs","volume":"340","author":"Balfour","year":"1999","journal-title":"N Eng J Med"},{"issue":"1","key":"10.6061\/clinics\/2015(07)09_bib77","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/sj.bmt.1705671","article-title":"Active CMV disease does not always correlate with viral load detection","volume":"40","author":"Ruell","year":"2007","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.6061\/clinics\/2015(07)09_bib78","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1055\/s-2006-945530","article-title":"Major complications following hematopoietic stem cell transplantation","volume":"27","author":"Afessa","year":"2006","journal-title":"Semin Respir Crit Care Med"},{"issue":"1","key":"10.6061\/clinics\/2015(07)09_bib79","first-page":"78","article-title":"Risk factors for the development of cytomegalovirus disease after allogeneic stem cell transplantation","volume":"91","author":"Ljungman","year":"2006","journal-title":"Haematologica"},{"issue":"5 Pt 1","key":"10.6061\/clinics\/2015(07)09_bib80","first-page":"638","article-title":"Cytomegalovirus infection and survival in lung transplant recipients","volume":"10","author":"Duncan","year":"1991","journal-title":"J Heart Lung Transplant"},{"issue":"1","key":"10.6061\/clinics\/2015(07)09_bib81","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0022-5223(95)70419-1","article-title":"Analysis of time-dependent risk for infection, rejection, and death after pulmonary transplantation","volume":"109","author":"Bando","year":"1995","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"2","key":"10.6061\/clinics\/2015(07)09_bib82","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/01.TP.0000165430.65645.4F","article-title":"Management of cytomegalovirus infection in lung transplant recipients: evidence-based recommendations","volume":"80","author":"Zamora","year":"2005","journal-title":"Transplantation"}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222013618?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222013618?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/clinics.org.br\/uploads\/artigos\/cln-70-7\/cln-70-07-515.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T07:02:32Z","timestamp":1761721352000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1807593222013618"},"secondary":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_abstract&pid=S1807-59322015000700515&lng=en&nrm=iso","label":"SCIELO"},{"URL":"http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4496754\/?report=classic","label":"PMC"}]},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":82,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S1807593222013618"],"URL":"https:\/\/doi.org\/10.6061\/clinics\/2015(07)09","relation":{},"ISSN":["1807-5932"],"issn-type":[{"value":"1807-5932","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytomegalovirus infection in transplant recipients","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.6061\/clinics\/2015(07)09","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 CLINICS. Published by Elsevier Spain","name":"copyright","label":"Copyright"}]}}